Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Queen's University
With
Pfizer
Glaucoma Research Society of Canada
Patients who have been chosen to undergo SLT for glaucoma will be randomized to receive one of prednisolone 1%, ketorolac 0.5% or artificial tears four times a day for 5 days following administration of the laser treatment. The IOP will be measured at various time points following SLT: 1 hour, 2 days, 1 week, 1 month, 3 months, 6 months, and 1 year.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
primary open angle glaucoma, pseudo exfoliation glaucoma